$2.42
0.63% today
NYSE, Apr 01, 06:17 pm CET
ISIN
US68218J1034
Symbol
OABI
Sector
Industry

OmniAb Stock price

$2.40
-1.08 31.03% 1M
-1.83 43.26% 6M
-1.14 32.20% YTD
-2.96 55.22% 1Y
-6.39 72.70% 3Y
-6.39 72.70% 5Y
-6.39 72.70% 10Y
NYSE, Closing price Mon, Mar 31 2025
-0.02 0.83%
ISIN
US68218J1034
Symbol
OABI
Sector
Industry

Key metrics

Market capitalization $290.43m
Enterprise Value $254.16m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 9.63
P/S ratio (TTM) P/S ratio 11.01
P/B ratio (TTM) P/B ratio 1.01
Revenue growth (TTM) Revenue growth -22.75%
Revenue (TTM) Revenue $26.39m
EBIT (operating result TTM) EBIT $-74.21m
Free Cash Flow (TTM) Free Cash Flow $-41.54m
Cash position $59.43m
EPS (TTM) EPS $-0.61
P/E forward negative
P/S forward 12.61
EV/Sales forward 11.04
Short interest 6.73%
Show more

Is OmniAb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

OmniAb Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a OmniAb forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a OmniAb forecast:

Buy
100%

Financial data from OmniAb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
26 26
23% 23%
100%
- Direct Costs 21 21
10% 10%
79%
5.51 5.51
64% 64%
21%
- Selling and Administrative Expenses 3.73 3.73
58% 58%
14%
- Research and Development Expense 55 55
3% 3%
209%
-53 -53
6% 6%
-202%
- Depreciation and Amortization 21 21
10% 10%
79%
EBIT (Operating Income) EBIT -74 -74
7% 7%
-281%
Net Profit -62 -62
23% 23%
-235%

In millions USD.

Don't miss a Thing! We will send you all news about OmniAb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OmniAb Stock News

Neutral
Seeking Alpha
14 days ago
OmniAb, Inc. (NASDAQ:OABI ) Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ET Company Participants Kurt Gustafson - Chief Financial Officer Matt Foehr - President & Chief Executive Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Kripa Devarakonda - Truist Securities Operator Good afternoon and welcome to OmniAb Inc's Fourth Quarter and Full Year 2024 Financial Resu...
Neutral
Business Wire
14 days ago
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2024, and provided operating and partner program updates. “2024 was a remarkable year featuring double-digit percentage growth in the number of both active partners and programs. Clinical-stage programs advanced well, and we launched new technologies a...
Neutral
Business Wire
about one month ago
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Tuesday, March 18, 2025 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What:   OmniAb conference call to discuss fourth quart...
More OmniAb News

Company Profile

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Head office United States
CEO Matthew Foehr
Employees 114
Founded 2015
Website www.omniab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today